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Out-of-hospital Administration of Mannitol 
to Head-injured Patients Does Not Change Systolic 
Blood Pressure 
Michael R. Sayre. MD, Stephen W Daily, MD, Susan A. Stern, MD, Daniel L. Storer; MD, 
Harry R. van Loveren, MD, James M. Hurst, M D  
I ABSTRACT 
Objective: To determine the effect of out-of-hospital mannitol administration on systolic blood pressure (BP) 
in the head-injured multiple-trauma patient. 
Methods: This was a prospective, randomized, double-blind, placebo-controlled clinical trial involving a 
university-based helicopter air medical service and level- 1 trauma center hospital. Endotracheally intubated 
head-trauma victims with Glasgow Coma Scale (GCS) scores c 12 were enrolled from November 22, 1991, 
to November 20, 1992, if evaluated by the participating aeromedical transport team within 6 hours of injury. 
Patients were excluded if they were e l 8  years old, had already received mannitol or another diuretic, were 
potentially pregnant, or were receiving CPR. All patients were intubated prior to study drug (mannitol [l g/ 
kg] or normal saline) use. Pulse and BP yere measured every 15 minutes for 2 hours following study drug 
administration. 
Results: A total of 44 patients were enrolled. After exclusion of 3 patients who did not meet all inclusion 
criteria, there were 20 patients in the mannitol group and 21 patients in the placebo group. The groups were 
similar at baseline in age, pulse, systolic BP (baseline mannitol: 124 t 47 mm Hg; placebo: 128 2 32 mm Hg), 
GCS score, and Injury Severity Scale score. Systolic BP did not change significantly throughout the obser- 
vation period in either group. This study had 83% power to detect a mean systolic BP drop to <90 mm Hg. 
Conclusion: Out-of-hospital administration of mannitol did not significantly change systolic BP in this group 
of head-injured multigle-trauma patients. 
Key words: head injury; brain injury; mannitol; emergency medical services; patient transport; 
hemodynamics- blood pressure. 
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I The most common cause of death in the United 
States among persons aged 1-44 years is injury. ~ p -  
proximately 50% of all trauma deaths are due to head 
injury,' and there are about 19 head-injury deaths an- 
nually per ~00,000 U.S. residents.2 At the present time, 
the optimal treatment for severe head injury is unknown. 
One of the mechanisms for the high morbidity and 
mortality associated with head injury is a rise in intra- 
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cranial pressure (ICP) with subsequent neutonal ische- 
mia. Published recommendations for the management of 
elevated ICP include endotracheal intubation and hyper- 
ventilation followed by IV administration of mannitol 
only when elevated ICP is proven or strongly sus- 
p e ~ t e d . ~ . ~  However, some physicians are concerned about 
possible hemodynamic instability, which might result 
from the osmotic diuresis following mannitol adminis- 
tration in a multiple-trauma patient.’ Based on this con- 
cern, some trauma systems discourage the use of man- 
nitol prior to volume resuscitation and stabilization of 
the patient. There are few data to support the recom- 
mendation to withhold mannitol, and this approach may 
deprive head-injured patients of beneficial 
Previous studies involving mannitol administration have 
been conducted in the intensive care unit (ICU). oper- 
ating theater, and ED. Little work has focused on the use 
of mannitol before hospital arrival. 
The purpose of this study was to assess the safety of 
niannitol administration to the head-injured multiple- 
trauma patient in the out-of-hospital emergency care set- 
ting. We hypothesized that early administration of man- 
nitol in the out-of-hospital setting would have no effect 




This was a prospective, randomized, double-blind, 
placebo-controlled clinical trial of the effect of mannitol 
on systolic BP in multiply injured patients with severe 
head injuries. The research protocol was approved by 
the University of Cincinnati Institutional Review Board 
(IRB), with a waiver of prospective informed consent. If 
they were available, the patient’s family were apprised 
of the study as soon as possible after hospital arrival. 
Setting and Participants 
Specific trauma patients who were being transported 
by a university hospital-based helicopter air medical ser- 
vice to that hospital’s level-1 trauma center from No- 
vember 22, 1991, through November 20, 1992, were 
considered for enrollment. The air medical service trans- 
ports approximately 625 trauma patients per year. Eli- 
gibility for entry into the study was determined by the 
flight crew. The flight team consisted of an experienced 
flight nurse and an emergency medicine (EM) resident 
physician. The flight crew was able to perform endotra- 
cheal intubation followed by hyperventilation with a 
portable ventilator after loading the patient into the air- 
craft. In addition, the medical team camed non-cross- 
matched blood for administration to patients with hem- 
orrhagic shock. 
Head-injured patients were eligible for inclusion if 
they had a Glasgow Coma Scale (GCS) score c 12, had 
IV access, had airway control with an endotracheal tube, 
and were being hyperventilated. In addition, they had to 
be entered into the study within 6 hours of injury. 
Patients were excluded if they were <18 years old, 
had received mannitol or another diuretic since the time 
of the traumatic incident, or were undergoing CPR. At 
the request of the IRB, women 4 0  years old were ex- 
cluded, unless their medical records clearly documented 
a previous tuba1 ligation or hysterectomy. 
Experimental Protocol 
As soon as possible after intubation and stabilization 
of the patient’s airway and breathing, the study solution 
was administered. Patients were randomized to either 
control or treatment groups by block randomization. The 
control group received 5 m L k g  of 0.9% saline solution 
(308 mOsmoVL), while the treatment group received 5 
mLkg of 20% mannitol (1,098 mOsmoYL). The latter 
volume of solution provides a dose of 1 g k g  of man- 
nitol. The study solution was administered as rapidly as 
possible through a blood filter into a large-bore IV cath- 
eter. The flight crew was instructed to pump the solution 
into the patient so that it would be administered over as 
little as 5 minutes.’ No additional mannitol or other di- 
uretic was administered during the remainder of the 
transport. 
The study solutions were prepared by the pharmacy 
department and were identified by a code number. An 
envelope showing the code number identified the con- 
tents of that IV bag. If the treating physicians at the 
receiving trauma center believed it was necessary to 
know whether the patient had received mannitol or pla- 
cebo, the envelope could be opened. 
Measurements 
Data were collected just prior to and immediately 
after administration of head injury solution, at least 
every 15 minutes during transport, upon arrival in the 
ED, and every 15 minutes thereafter for 2 hours. Each 
data set included time of day, systolic and diastolic BPs, 
heart rate, respiratory rate, airway status (controlled or 
spontaneous respirations), IV solution(s) being infused, 
volume infused, and flow rate. In addition, GCS scores 
were obtained on initial patient contact, upon arrival in 
the ED, and at the end of the 2-hour study period. All 
the patients received Foley catheters, and urine outputs 
were recorded with the E D  data sets. At the end of the 
2-hour observation period, the results of arterial blood 
gases (ABGs), electrolytes, and CT scans were recorded. 
The presence or absence of inflated pneumatic antishock 
garments was recorded as well. 
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I TABLE 1 Baseline Patient Characteristics (Mean ? SD) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
~~ ~~~ 
Mannitol Placebo 
(n  = 20) (n = 21) p-value 
Age 29 2 12 years 27 2 8 years 0.62 
Pulse 99.5 t 23.0 beats/min 105.0 t 18.0 beatslmin 0.41 
Systolic blood pressure 124 2 47 mm Hg 123 t 32 mm Hg 0.80 
Interval from trauma until initiation of study infusion 66 2 30 min 66 2 47 min 0.96 
0.59 No. flown directly from injury scene 
No. with initial systolic blood pressure <90 mm Hg 6 (30%) 3 (14%) 0.22 
Volume IV fluid administered prior to flight team arrival 700 ? 730 mL 748 2 659 mL 0.83 
No. with > I  L JV fluid prior to flight team arrival 3 (14%) 4 (19%) 0.73 
No. with pneumatic antishock garment inflated prior to flight team anival 4 (19%) 0.94 
No. with blood administered prior to flight team arrival 1(5%)  0 (0%) 0.30 
Glasgow Coma Scale score 7.1 6.4 0.43 
No. men 19 (95%) 20 (95%) 0.97 
No. intubated prior to flight team arrival 9 (45%) 14 (70%) 0.16 
No. with ethanol >O mg/dL [>O mmollL] 6 (30%) 5 (24%) 0.65 
19 (90%) 17 (85%) 
4 (20%) 
Ethanol level for those with ethanol present 189 2 45 mg/dL 167 5 51 mg/dL 0.22 
[41 t 10 mmol/L] [36 t 1 1  mmol/L] 
Other data collected by chart review included 
whether the patient survived to hospital discharge, ICP 
monitoring data, and other neurologic procedures and 
diagnostic tests performed. Injury Severity Scale (ISS) 
scores using the AIS-90 classification were calculated by 
an experienced trauma registrar, based on injuries dis- 
covered during the patient’s hospitalization or autopsy.” 
The TRISS method was used to predict the probability 
of survival.” 
Data Analysis 
The treatment groups were compared for baseline 
parameters, as well as primary and secondary endpoints. 
The primary study endpoint was the change in systolic 
BP during the 2-hour observation period. Secondary end- 
points included a change in pulse rate, the volume of IV 
solution administered, and urinary output. 
I TABLE 2 Mechanism of Injury and Injury Seventy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Mannitol Placebo 
( n  = 20) ( n  = 21) 
Mechanism 





Injury Severity Scale score (median) 































Data were analyzed using the rank sum test, Fisher’s 
exact test, analysis of variance (ANOVA), and Dunnett’s 
multirange test. All statistical tests were 2-tailed. Statis- 
tical comparisons were performed using Statistix 3.5 
(Analytical Software, St. Paul, MN), JMP Statistical 
Software 2.0.5 (SAS Institute, Inc., Cary, NC), and Mi- 
crosoft Excel 5.0 (Microsoft Corp., Redmond, WA). An 
cx < 0.05 was considered significant. 
I RESULTS . . . . . . . . . . . . . . . . . . .  
A total of 44 patients were enrolled in the study. How- 
ever, 3 patients were excluded from analysis for the fol- 
lowing reasons: the study solution infusion was discon- 
tinued by the attending emergency physician prior to 
completion because he did not believe that the patient 
had a head injury (n = 1); the patient received a dose of 
furosemide prior to enrollment (n = 1); and the patient 
was found to have had a hemorrhagic stroke rather than 
a head injury (n = 1). The latter patient was found un- 
responsive in her vehicle after a minor traffic collision. 
She was taken to an outlying hospital and then trans- 
ferred to the trauma center. Because of her depressed 
mental status with a GCS score of 3, she was assumed 
to have a head injury and was entered into the study. 
This patient received normal saline. After arrival at the 
trauma center, a CT scan of the brain revealed that she 
had an intracerebral hemorrhage consistent with a spon- 
taneous bleed. No injury was identified. 
All the patients who were not intubated before flight 
team arrival were intubated prior to administration of the 
study fluid. Of the remaining 41 patients, 20 received 
mannitol and 21 received placebo. The groups were sim- 
ilar with regard to age and baseline pulse, systolic BP, 
and GCS score (Table 1). No difference was found be- 
tween the mannitol and placebo groups in overall ISS 
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score or head injury severity as measured by the injury 
scale for head and neck (Table 2). Mortality was 25% in 
the mannitol group and 14% in the placebo group (p = 
0.38 by Fisher’s exact test). Table 3 describes the types 
of head injuries found in the enrolled patients. 
The systolic BP did not change significantly during 
the 2-hour observation period (Fig. 1). Two hours after 
hospital arrival, systolic BP was lower in the mannitol 
group than in the placebo group (1 16 2 24 mm Hg vs 
142 5 25 mm Hg, p < 0.003). However, when all time 
periods (including baseline values) were compared using 
ANOVA, there was no overall difference in systolic BP 
between the mannitol and placebo groups. There were 6 
patients in the mannitol group and 3 patients in the con- 
trol group who were hypotensive, with systolic BPs <90 
mm Hg at the time of entry into the study. Figure 2 
details the courses of these 9 patients during the obser- 
vation period. Two initially hypotensive patients in both 
the mannitol and the placebo groups died. 
The patients’ pulse rates did not change significantly, 
and there was no difference found between the mannitol 
and placebo groups at any time (Fig. 3). There was no 
difference in study volume administered to the groups: 
the mannitol patients received 428 2 61 mL and the 
placebo patients received 410 2 73 mL of study fluid. 
Overall, the mannitol patients received 4,360 t 4,520 
I TABLE 3 Types of Head Injuries Found in Enrolled Patients 
Mannitol Placebo 
(n = 21) (n  = 20) 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Injury 
Gunshot wound 2 1 
Brain contusion or hemorrhage 8 6 
Concussive injury without fracture 5 8 
Intracranial vascular injury 0 2 
1 1 Open skull fracture 
Isolated closed skull fracture 1 1 
Epidural hematoma 1 0 
No brain injury found 2 2 
Number with operative neurosurgical 2 2 
procedures 
mL of IV fluid over the 2 hours, while the control pa- 
tients received 2,530 2 1,110 mL of IV fluid (p = 0.20) 
(Fig. 4). The variance in overall volume administered 
was significantly greater for the mannitol group (F = 16, 
p c 0.001). This large variance is due in part to 1 patient 
in the mannitol group who received 17,500 mL of IV 
fluid (including 6 units of blood) for ongoing hemor- 
rhage, while having a urine output of only 15 mL over 
the 2-hour monitoring period. 
Urine output was 1,351 * 608 mL and 634 -+ 444 
mL in the mannitol and placebo groups, respectively (p 
c 0.001). The osmotic effect of mannitol also was re- 
+Placsbo Mean +I- 95% CI 
Minutes after Am’val 
I FIGURE 1. Systolic blood pressure (BP) from first contact with the flight team though 2 hours after hospital arrival. Plotted values are means, 
and the error bars represent 95% CIS for the means. 
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Minutes after Arrival 
I FIGURE 2. Systolic blood pressure (BP) changes over the 2-hour observation period for the 9 patients who had a systolic BP <90 mm Hg 
when first contacted by the flight team. 
Minutes afbr  Arrival 
I FIGURE 3. Pulse rate from first contact with the flight team though 2 hours after hospital arrival. Plotted values are means. and the error bars 
represent 95% CIS for the means. 
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flected in the patients' electrolyte levels. On hospital ar- 
rival, serum sodium was 130.6 2 5.8 and 139.1 2 2.1 
in the mannitol and placebo groups, respectively (p < 
0.00001). Serum osmolarity was calculated rather than 
measured in the laboratory. Eight (40%) of the patients 
in the mannitol group and 4 (19%) of the patients in the 
placebo group received blood transfusions after admin- 
istration of the study fluid (p = 0.14). 
The patients were moderately hyperventilated on 
hospital arrival. Initial ABG analysis revealed the fol- 
lowing values for the mannitol and placebo groups, re- 
spectively: pH 7.30 -+ 0.16 and 7.33 ? 0.18; PO, 298 
5 148 and 327 5 193 torr; and Pco, 34 5 7.5 and 33 
2 11 torr. There was no statistically significant differ- 
ence between the groups. 
Using the TRISS methodology, both groups had bet- 
ter than expected outcomes, although the distribution of 
ISS scores did not march the Major Trauma Outcome 
Study (MTOS) norms." The mannitol group Z-score was 
-2.6; and the placebo group Z-score was -3.3. 
A post-hoc power analysis was performed. Using the 
means and SDs found in the study sample, there was an 
83% chance of detecting a fall in mean systolic BP to 
<90 mm Hg. 
During the 2-hour monitoring period, the treating 
physicians requested that the identity of the study fluid 
be unblinded for 2 patients (11%) who had received 
mannitol and 3 patients (15%) who had received pla- 
cebo. 
At the conclusion of the 2-hour monitoring period, 
the EM resident and the investigator recording the pa- 
tient data were asked to provide their guesses as to 
whether mannitol or placebo had been administered to 
the patient. For those patients actually given mannitol, 
the resident correctly picked mannitol in 11 of 13 cases 
for which a guess was given; and the investigators cor- 
rectly picked mannitol in 13 of 14 cases. For those pa- 
tients actually given placebo, the resident correctly 
picked placebo in 5 of 10 cases for which a guess was 
given; and the investigators correctly picked placebo for 
13 of 16 cases. 
I DISCUSSION 
Mannitol has been shown to have a number of effects 
that are likely to be beneficial in the brain-injured pa- 
tient. Its precise mechanism of action is unclear, but it 
is likely more complex than simply lowering ICP by 
dehydrating brain tissue. Mannitol may have a cerebro- 
protective effect by limiting secondary ischemic injury,', 
and it may improve cerebral perfusion by decreasing 







Minutes after Arrival 
I FIGURE 4. IV fluid volume administered from first contact with the flight team though 2 hours after hospital amval. Plotted values are means. 
and the error bars represent 95% CIS for the means. 
~ ~~ 
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mation of cerebrospinal fluid.I5 It is clear that adminis- 
tration of mannitol carries some risk of adverse effects 
such as acute renal failure,I6 and transient hypotension 
lasting <5 minutes has been reported after very rapid 
administration of mannitol in the operating suite.I7 Mul- 
tiple doses of mannitol may actually increase water con- 
tent in injured cerebral tissues because the blood-brain 
barrier is disrupted.I8 
Few studies have examined the use of mannitol prior 
to hospital arrival of the head-injured patient. We at- 
tempted to examine the safety of out-of-hospital admin- 
istration of mannitol in multiply injured patients with 
head injuries. Data from this pilot investigation suggest 
that out-of-hospital mannitol administration does not sig- 
nificantly change systolic BP in head-injured multiple- 
trauma patients. There is an insufficient number of pa- 
tients in this pilot study to assess whether out-of-hospital 
mannitol administration to head-injured patients with 
other concomitant injuries is beneficial overall. 
This investigation was initiated because some phy- 
sicians have expressed concern that empiric administra- 
tion of IV mannitol may adversely affect a trauma pa- 
tient’s hemodynamic status. Specifically, they suggest 
that mannitol administration may cause hypotension and 
further compromise cerebral perfusion.’ 
Based on this concern, many centers administer man- 
nitol only after directly measuring ICP. However, in a 
study designed to assess the impact of ICP monitoring 
on outcome from severe head injury, no difference in 
outcome was found between ICU patients receiving em- 
piric mannitol and those receiving mannitol only for 
documented ICPs > 25 mm Hg.” Since there was not a 
placebo control in that study, it is unknown whether 
mannitol administration was detrimental or beneficial for 
both those patients with very high ICPs and those with 
lesser degrees of ICP elevation. If mannitol were of ben- 
efit for patients with mild elevations in ICP, a more lib- 
eral policy of mannitol administration would be gener- 
ally beneficial. 
It is commonly taught that mannitol should be given 
only when hyperventilation has been tried and failed to 
produce the desired reduction in ICP.20 However, there 
is evidence that prolonged hyperventilation is harmful 
and that relative normocapnia such as found in our pa- 
tients is desirable.2’.22 
Animal research suggests that mannitol administra- 
tion improves hemodynamic parameters. In a dog model 
of concomitant increased ICP and hemorrhagic shock, 
administration of mannitol significantly decreased ICP 
while simultaneously increasing mean arterial pressure 
(MAP).23 Other animal hemorrhage studies also have 
demonstrated that mannitol administration increases BP, 
although, unlike solutions containing dextran 70, the hy- 
pertensive effect is not maintained.“-26 Our data support 
the conclusions of these animal studies that mannitol 
does not have an adverse effect on systemic hemody- 
namic parameters such as systolic BP or pulse rate. 
Mannitol administration in an ICU setting does not 
appear to adversely effect hem~dynamics .~~  In a study 
of 16 ICU patients with elevated ICPs, Rosner and Coley 
demonstrated that when cerebral perfusion pressure 
(CPP) was compromised (<70 mm Hg), administration 
of mannitol resulted in an increase in MAP, a decrease 
in ICP, and an improvement of CPP. For patients with 
CPPs >70 mm Hg, mannitol was found to have little 
effect on any hemodynamic parameter.28 
Because empiric administration of mannitol to ICU 
patients does not appear to be harmful and because oth- 
ers have found evidence for improved outcome when 
mannitol and endotracheal intubation were used,29 a pol- 
icy of empiric mannitol administration in the out-of-hos- 
pita1 setting to trauma patients with evidence for head 
injury might be beneficial. The purpose of our study was 
to test whether empiric out-of-hospital administration of 
mannitol was safe, before proceeding with a future trial 
to demonstrate efficacy. 
This study demonstrated that out-of-hospital admin- 
istration of mannitol to trauma patients with abnormal 
GCS scores did not adversely change systolic BP. During 
the observation period, there was no significant differ- 
ence from baseline in either the mannitol or the placebo 
group. Supporting evidence that there was no significant 
hemodynamic effect is provided by the fact that there 
was no difference between the mannitol and the control 
groups’ pulse rates during the observation period. 
I LIMITATIONS AND FUTURE 
QUESTIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Before application of the results of this study, its limi- 
tations must be considered. First, the study was not de- 
signed to detect differences in mortality rates. Given the 
overall mortality rate of 20%, 1,447 patients would be 
needed in each group to detect an absolute mortality dif- 
ference of 4%. 
Second, some might argue that the most sensitive 
hemodynamic parameter to follow in trauma patients is 
the diastolic BP. In both out-of-hospital care and ED care 
of these unstable trauma patients, BP was frequently 
measured using palpation techniques or Doppler stetho- 
scopes. Therefore, the diastolic BP was not regularly ob- 
tained. Systolic BP is currently the most practical and 
frequently followed hemodynamic parameter in out-of- 
hospital and ED trauma patients. 
Third, this study was limited by the fact that we in- 
cluded patients with blunt and penetrating head injuries. 
Penetrating-head-injury patients with GCS scores of 3 
have essentially 100% mortality, and these patients prob- 
ably should be excluded from future investigations. A 
reanalysis of the data with the 3 penetrating trauma pa- 
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tients excluded reveals a mortality rate of 17% vs 10% 
(mannitol vs control). 
Some readers might question the dose of mannitol 
used for the study. Mannitol usually is administered in 
doses from 0.25 g k g  to 1.0 gkg .  In a study by Marshall 
et al., a dose of 0.25 g k g  produced the same reduction 
in ICP as did higher doses.30 In contrast, Roberts et al. 
demonstrated a dose-dependent effect of mannitol on 
ICP red~ct ion.~ '  Other studies suggest that a higher man- 
nitol dose is needed to elevate cardiac output and BP 
(e.g., 0.5 g/kg,32 0.72 g/kg,24 1.0 gJkg,*' and 2.0 g l l ~ g ~ ~ ) .  
Because it is unclear how much mannitol is needed to 
produce maximal reduction in ICP and because higher 
doses of mannitol appear to elevate MAP under some 
circumstances, a dose of 1.0 g k g  was chosen for use in 
this trial in hopes of empirically optimizing CPP. 
Nine patients in this study were hypotensive at the 
time of enrollment. However, as demonstrated in Figure 
2, no consistent effect on systolic BP was seen for these 
patients. Of note, 2 (both control patients) did not sur- 
vive the 2-hour observation period. A larger study of 
initially hypotensive patients is warranted, especially in 
light of recent animal evidence that administration of 
hypertonic fluids may improve hemodynamics in head 
injury with concomitant hemorrhagic and in 
light of recent clinical data that normal saline adminis- 
tration to victims of penetrating torso trauma is not ben- 
eficia~.'~ 
I CONCLUSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Out-of-hospital administration of 1 .O g k g  of mannitol to 
the multiple-trauma patient with head injury is not as- 
sociated with any significant change in systolic BP or 
pulse rate. Before routine out-of-hospital administration 
of mannitol to all head-injured, multiple-trauma patients 
can be recommended, larger clinical trials are needed to 
determine the effect on neurologic outcome and mortal- 
ity. 
Supported by grants from the Aeromedical Research Foundation and 
the Department of Emergency Medicine, University of Cincinnati. The 
authors acknowledge the contributions of the flight nurses and flight 
physicians of University Air Care, who made this investigation pos- 
sible. 
I REFERENCES 
Gennarelli TA, Champion HR, Copes WS, Sacco WJ. Compari- 
son of mortality, morbidity, and severity of 59.713 head injured 
patients with 114,447 patients with extracranial injuries. J 
Trauma. 1994; 37:962-8. 
Sosin DM, Sniezek JE, Waxweiler RJ. Trends in death associated 
with traumatic brain injury, 1979 through 1992. JAMA. 1995; 
Fessler RD, Diaz FG. The management of cerebral perfusion 
pressure and intracranial pressure after severe head injury. Ann 
273: 1778 -80. 
Emerg Med. 1993; 22:998- 1003. 
4. Committee on Trauma. Advanced Trauma Life Support. Chicago: 
American College of Surgeons, 1993. 
5. Feldman JA, Fish S. Resuscitation fluid for a patient with head 
injury and hypovolemic shock. J Emerg Med. 1991; 9:465-8. 
6. Rosner MJ, Daughton S. Cerebral perfusion pressure management 
in head injury. J Trauma. 1990; 30:933-41. 
7. Klauber MR. Marshall LF. Toole EM, Knowlton SL, Bowers SA. 
Cause of decline in head injury mortality rate in San Diego 
County, California. J Neurosurg. 1985; 62:528-31. 
8. Rosner MJ. Rosner SD, Johnson AH. Cerebral perfusion pressure: 
management protocol and clinical results. J Neurosurg. 1995; 
83:949-62. 
9. Ravussin P, Archer DP. Tyler JL, et al. Effects of rapid mannitol 
infusion on cerebral blood volume. A positron emission tomo- 
graphic study in dogs and man. J Neurosurg. 1986; 64:104-13. 
10. American Association for Automotive Medicine. The Abbrevi- 
ated Injury Scale (AIS)-I990 Revision. Des Plaines, IL: 
AAAM, 1990. 
11. Boyd CR, Tolson MA, Copes WS. Evaluating trauma care. The 
TRISS method. J Trauma. 1987; 27:370-8. 
12. Luvisotto TL, Auer RN, Sutherland GR. The effect of mannitol 
on experimental cerebral ischemia, revisited. Neurosurgery. 1996; 
13. Muizelaar JP. Wei EP, Kontos HA, Becker DP. Mannitol causes 
compensatory cerebral vasoconstriction and vasodilation in re- 
sponse to blood viscosity changes. J Neurosurg. 1983; 59:822- 
8. 
14. Hartwell RC, Sutton LN. Mannitol, intracranial pressure, and va- 
sogenic edema. Neurosurgery. 1993; 32:444-50. 
15. Donato T, Shapira Y, Artru A, Powers K. Effect of mannitol on 
cerebrospinal fluid dynamics and brain tissue edema. Anesth An- 
alg. 1994; 78:58-66. 
16. Oken DE. Renal and extrarenal considerations in high-dose man- 
nitol therapy. Renal Failure. 1994; 16:147-59. 











to rapid intravenous administration of hypertonic solutions in man 
and in the rabbit. Anesthesiology. 1979; 50:30-5. 
Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral 
edema by multiple-dose mannitol. J Neurosurg. 1992; 77:584-9. 
Smith HP, Kelley DL Jr, McWhorter JM, et al. Comparison of 
mannitol regimens in patients with severe head injury undergoing 
intracranial monitoring. J Neurosurg. 1986; 65:820-4. 
Cruz J. An additional therapeutic effect of adequate hyperventi- 
lation in severe acute brain trauma: normalization of cerebral glu- 
cose uptake. J Neurosurg. 1995; 82:379-85. 
Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of 
prolonged hyperventilation in patients with severe head injury: a 
randomized clinical trial. J Neurosurg. 1991; 75:73 1-9. 
Ghajar J, Hariri RJ, Narayan RK, Iacono LA. Firlik K, Patterson 
RH. Survey of critical care management of comatose, head- 
injured patients in the United States. Crit Care Med. 1995; 
Israel RS. Marx JA, Moore EE, Lowenstein SR. Hernodynamic 
effect of mannitol in a canine model of concomitant increased 
intracranial pressure and hemorrhagic shock. Ann Emerg Med. 
Smith GJ, Kramer GC, Perron P, Nakayama S, Gunther RA, Hol- 
croft JW. A comparison of several hypertonic solutions for resus- 
citation of bled sheep. J Surg Res. 1985; 39:517-28. 
Rabelo A, Litwin MS, Brady MP, Moore FD. A comparison of 
the effects of several osmotic diuretic agents after acute hemor- 
rhage in the dog. Surg Gynecol Obstet. 1962; 115:657-70. 
Irvin CB, Syverud SA. Dronen SC. Chudnofsky CR. Effect of 
hypertonic versus normotonic resuscitation on intracranial pres- 
sure after combined head injury and hemorrhagic shock [abstract]. 
23:560-7. 
1988; 17:560-6. 









. . . .  
Ann Emerg Med. 1989; 18:477. 
Cruz J, Jaggi JL, Hoffstad OJ. Cerebral blood flow. vascular re- 
sistance, and oxygen metabolism in acute brain trauma: redefin- 
ing the role of cerebral perfusion pressure? Crit Care Med. 1995; 
Rosner MJ, Coley I. Cerebral perfusion pressure: a hemodynamic 
mechanism of mannitol and the post-mannitol hemogram. Neu- 
rosurgery. 1987; 21: 147-56. 
Baxt WG, Moody P. The impact of advanced prehospital emer- 
gency care on the mortality of seriously brain injured patients. J 
Trauma. 1987; 27:365-9. 
Marshall LE Smith RW, Rauscher LA. Shapiro HM. Mannitol 
dose requirements in brain injured patients. J Neurosurg. 1978; 
Roberts PA, Pollay M, Engles C, Pendleton B, Reynolds E. Ste- 
vens FA. Effect on intracranial pressure of furosemide combined 
with varying doses and administration rates of mannitol. J Neu- 
rosurg. 1987; 66:440-6. 
Brown FD, Johns L, Jafar JJ, Crockard HA, Mullan S. Detailed 
monitoring of the effects of mannitol following experimental head 
injury. J Neurosurg. 1979; 50:423-32. 
Freshman SP, Battistella FD, Matteucci M. Wisner DH. Hyper- 
tonic saline (7.5%) versus mannitol: a comparison for treatment 
of acute head injuries. J Trauma. 1993: 35:344-8. 
Bickell WH, Wall MJ Jr. Pepe PE, et al. Immediate versus de- 
layed fluid resuscitation for hypotensive patients with penetrating 
torso injuries. N Engl J Med. 1994; 331:1105-9. 
23:1412-7. 
48: 169 -72. 
Further Thoughts from the Reviewers 
patients with multiple trauma, represented a significant clinical 
concern. 
In December 1995, the American Association of Neuro- 
logical Surgeons (AANS) advanced a series of guidelines for 
the treatment of the severely traumatized head-injured patient. 
The AANS advocates the use of mannitol in circumstances in 
which the patient has signs of increased ICP or signs of de- 
teriorating neurologic status. By these new guidelines. man- 
nitol would not be given routinely to all patients with serious 
head trauma. 
At the time this study was conducted, resuscitation re- 
search was frequently performed with a waiver of informed 
consent or  “deferred” consent. Resuscitation research had 
been performed for many decades using these consenting 
mechanisms, since the U.S. regulatory research guidelines did 
not address circumstances in which patients would be too crit- 
ically ill o r  injured to provide prospective informed consent. 
Since 1993, deferred consent has been disallowed by the Office 
for the Protection from Research Risks. A more stringent in- 
terpretation of regulatory guidelines also has made it quite dif- 
ficult to apply a waver of prospective informed consent in 
resuscitation research. This is problematic since patients are 
unable to speak for themselves. and often no legally authorized 
representative can be found. As resuscitation researchers know, 
it has become nearly impossible to investigate potentially 
promising new therapies in the acute or critical care setting 
because of these regulatory restrictions. Based on the input 
from the resuscitation research community, the FDA and the 
NIH are currently developing new guidelines that should allow 
resuscitation research in the setting where prospective in- 
formed consent is not possible. 
This study may seem outdated given the current guidelines 
I This study was designed and executed in 1991-1992 with 
the intent of answering an important question for emergency 
physicians. At the time this study was conducted, many cli- 
nicians gave mannitol to all patients with serious head injuries. 
The potential hypotensive effects of mannitol, especially in 
for mannitol administration. However, the study results pro- 
vide important hemodynamic data relevant to those out-of-hos- 
pita1 multiple-trauma patients with head injuries who d o  war- 
rant mannitol administration. Clearly, mannitol administration 
is unlikely to produce significant hemodynamic deterioration. 
